Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01870479
Other study ID # S-20120118
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2013
Est. completion date March 2017

Study information

Verified date June 2018
Source University of Southern Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Main purpose: To determine if live music moderates the level of chemotherapy related anxiety, in patients with haematological cancer

The investigators hypothesize that live music:

1. Have an ameliorating effect on physical and psychological symptoms during chemotherapy treatment

2. May counteract the patients feeling of loss of identity and alienation in this particular group of cancer patients.

3. Is more effective in patients with good musical abilities.

4. Is more effective than taped music.

Method: Intervention groups:

1. Listening to patient-preferred live music during chemotherapy

2. Listening to patient-preferred taped music during chemotherapy

3. Standard care

Endpoints:

Primary: Level of anxiety measured by STAI. Secondary: Serum catecholamines.

Background: In order to establish the intervention procedures, the investigators have carried out a pilot study at the hematology department at Hospital of Southwest Denmark, including students from the Academy of Music and Dramatic Arts, Southern Denmark. The pilot results indicates that live music has an uplifting, pain relieving, and then releasing effect and that music has a positive impact on hospitalisation. According to the evaluation forms filled out by 243 cancer patients, the music experience has provided human anchorage/cohesion as a counterweight to disease fixation and alienation Chemotherapy involves major physical and psychological problems. Not much has been provided in the clinical setting which relieves the symptoms of anxiety associated with chemotherapy. A review of the literature illustrate the need for developing new potential areas of intervention that takes into account, that not only do cancer patients face challenges in everyday life ranging from physiological changes over social to psychological problems, but also during treatment procedures, which may cause a higher level of anxiety associated with these procedures, e.g., chemotherapy infusion.This project investigates to what degree live music may relieve some of these symptoms during treatment for haematological cancer. The project is created in order to both measure psychosocial effects as well as direct stress measures, i.e. serum catecholamine. These physiological changes are measured in order to shed light on the mechanism behind the potential effects of live music on discomfort in connection with chemotherapy treatment.

Perspectives: The vision of the project focus on strengthening the cancer patients' ability to cope with physiological and psychological issues during chemotherapy sessions and to make the patients conscious of music as an option in these coping efforts. Hopefully, the results will provide a scientific basis for an evaluation of the perspectives and the potentials of live music treatment during chemotherapy infusion among cancer patients.


Recruitment information / eligibility

Status Completed
Enrollment 143
Est. completion date March 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18+

- Newly diagnosed with malignant lymphoma and planned first line chemotherapy treatment

- Able to give informed consent

Exclusion Criteria:

- Patients who do not speak or understand Danish

- Patients who are deaf or blind.

- Any comorbidity that postpone planed chemotherapy for more than 4 weeks

- Patients with alcohol or drugs misuse problems as stated in the medical record.

- Patients with untreated mental illness as identified in the medical record

Study Design


Intervention

Other:
Live music

Taped music


Locations

Country Name City State
Denmark Aarhus University Hospital Aarhus Central Denmark Region
Denmark Herlev Hospital Copenhagen The Capital Region Of Denmark
Denmark Rigshospitalet Copenhagen The Capital Region Of Denmark
Denmark Hospital of Southwest Jutland Esbjerg Region Of Southwest Denmark
Denmark Odense University Hospital Odense Region Of Southwest Denmark
Denmark The Academy of Music and Dramatic Arts, Southern Denmark Odense Region Of Southwest Denmark
Denmark Roskilde Sygehus Roskilde Region Zealand

Sponsors (3)

Lead Sponsor Collaborator
Margrethe Langer Bro Danish Cancer Society, University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety (STAI) STAI-S Spielberger State-Trait Anxiety Scale-State Measurement of STAI after the 5. chemotherapy (on average 8 weeks after inclusion)
Secondary Serum catecholamines Blood samples Measured before and after each chemotherapy (at baseline and on average after 2, 4, 6, and 8 weeks after inclusion)
Secondary Nausea Patient diary Between each visit (at baseline and on average after 1, 3, 5, and 7 weeks after inclusion)
Secondary Quality of life Quality of Life Questionnaire: QLQ-C30 Visit 1, 2, 4, 6, 7. (at basline and on average after 2, 4, 6, and 8 weeks after inclusion)
Secondary Anxiety (HADS) Hospital Anxiety and Depression Scale (HADS) Visit 1, 2, 3 and 4 (at baseline and on average 2, 4, 6 weeks after inclusion)
Secondary Distress questionaire: The Distress Thermometer Visit 1, 2, 4 and 6 (at basline and on average after 2, 4, 6, and 8 weeks after inclusion)
Secondary Anxiety (STAI) STAI-S Spielberger State-Trait Anxiety Scale-State Measurement of STAI at baseline and after each chemotherapy 1 to 5 (on average 2, 4, 6 and 8 weeks after inclusion) as well as differences from baseline.